Although non-invasive techniques such as ultrasound and alanine aminotransferase (ALT) can assist in the diagnosis of NAFLD, there are currently no established molecular markers that serve as key indicators for NAFLD [34]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.